Any feedback?
Literature summary for 2.7.1.36 extracted from
- Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene (2008), Metab. Eng., 11, 13-19.
Application
| Application | Comment | Organism |
|---|---|---|
| synthesis | production of amorpha-4,11-diene by an engineered strain of Escherichia coli containing codon-optimized MevT and amorphadiene synthase operons, and additional copies of mevalonate kinase and amorphadiene synthase genes, which could be identified as rate-limiting enzymes | Escherichia coli |
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| expression in Escherichia coli | Escherichia coli |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Escherichia coli | - |
- |
- |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
